These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20598491)

  • 1. Variations in treatment policies and outcome for bladder cancer in the Netherlands.
    Goossens-Laan CA; Visser O; Wouters MW; Jansen-Landheer ML; Coebergh JW; van de Velde CJ; Hulshof MC; Kil PJ
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S100-7. PubMed ID: 20598491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical factors influence bladder cancer outcomes: a cooperative group report.
    Herr HW; Faulkner JR; Grossman HB; Natale RB; deVere White R; Sarosdy MF; Crawford ED
    J Clin Oncol; 2004 Jul; 22(14):2781-9. PubMed ID: 15199091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
    Osawa T; Abe T; Shinohara N; Harabayashi T; Sazawa A; Kubota K; Matsuno Y; Shibata T; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Mori T; Nonomura K
    Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
    Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radical cystectomy for superficial tumors in the BCG era].
    Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
    Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in management of early breast cancer in the Netherlands, 2003-2006.
    van Steenbergen LN; van de Poll-Franse LV; Wouters MW; Jansen-Landheer ML; Coebergh JW; Struikmans H; Tjan-Heijnen VC; van de Velde CJ
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S36-43. PubMed ID: 20620013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.
    Konety BR; Joslyn SA; O'Donnell MA
    J Urol; 2003 Mar; 169(3):946-50. PubMed ID: 12576819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management and outcome of bladder carcinoma in Ontario, 1982-1994.
    Hayter CR; Paszat LF; Groome PA; Schulze K; Mackillop WJ
    Cancer; 2000 Jul; 89(1):142-51. PubMed ID: 10897011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H
    Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older.
    Hollenbeck BK; Miller DC; Taub D; Dunn RL; Underwood W; Montie JE; Wei JT
    Urology; 2004 Aug; 64(2):292-7. PubMed ID: 15302481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
    Hellenthal NJ; Hussain A; Andrews PE; Carpentier P; Castle E; Dasgupta P; Kaouk J; Khan S; Kibel A; Kim H; Manoharan M; Menon M; Mottrie A; Ornstein D; Palou J; Peabody J; Pruthi R; Richstone L; Schanne F; Stricker H; Thomas R; Wiklund P; Wilding G; Guru KA
    BJU Int; 2011 Feb; 107(4):642-6. PubMed ID: 20575975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
    Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of radical cystectomy for patients with pT4 bladder cancer.
    Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M
    Int J Urol; 2008 Jan; 15(1):58-61. PubMed ID: 18184174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
    J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in quality of care for colon cancer between hospitals in the Netherlands.
    Elferink MA; Wouters MW; Krijnen P; Lemmens VE; Jansen-Landheer ML; van de Velde CJ; Siesling S; Tollenaar RA
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S64-73. PubMed ID: 20599339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
    deVere White RW; Katz MH; Steinberg GD
    J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
    [No Abstract]   [Full Text] [Related]  

  • 19. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital Quality Metrics for Radical Cystectomy: Disease Specific and Correlated to Mortality Outcomes.
    Khanna A; Saarela O; Lawson K; Finelli A; Haber GP; Lee B; Abouassaly R
    J Urol; 2019 Sep; 202(3):490-497. PubMed ID: 31009290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.